Intracellular Stock Target Price and Analyst Consensus

ITCI Stock  USD 128.25  0.21  0.16%   
The current analyst and expert consensus on Intracellular is Strong Buy, with 9 strong buy opinions. The current projected Intracellular target price consensus is 103.50 with 15 analyst opinions. Check out Macroaxis Advice on Intracellular to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
The most common way Intracellular Th analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Intracellular executives and customers to further validate their buy or sell advice. Intracellular buy-or-sell recommendation module provides average expert sentiment on the projected Intracellular Th target price to derive its highest and lowest estimates based on projected price volatility of 4.9125.
Lowest Forecast
94.19
Highest Forecast
114.89
Target Price
103.5
As of now, Intracellular's Gross Profit is increasing as compared to previous years. The Intracellular's current Gross Profit Margin is estimated to increase to 0.96, while Pretax Profit Margin is projected to decrease to (0.11). As of now, Intracellular's Total Stockholder Equity is increasing as compared to previous years. The Intracellular's current Accounts Payable is estimated to increase to about 27.4 M, while Other Liabilities is projected to decrease to under 2.7 M.
  
It's important to approach Intracellular's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

Intracellular Target Price Consensus

Intracellular target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Intracellular's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   15  Strong Buy
Strong BuyBuyHoldStrong Buy60.0%Buy33.3%Hold6.7%Sell0.0%Strong Sell0.0%100%
Most Intracellular analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Intracellular stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Intracellular Th, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Intracellular Target Price Projection

Intracellular's current and average target prices are 128.25 and 103.50, respectively. The current price of Intracellular is the price at which Intracellular Th is currently trading. On the other hand, Intracellular's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Intracellular Market Quote on 28th of February 2025

Low Price128.2Odds
High Price128.63Odds

128.25

Target Price

Analyst Consensus On Intracellular Target Price

Low Estimate94.19Odds
High Estimate114.89Odds

103.5

Historical Lowest Forecast  94.19 Target Price  103.5 Highest Forecast  114.89
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Intracellular Th and the information provided on this page.

Intracellular Analyst Ratings

Intracellular's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Intracellular stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Intracellular's financials, market performance, and future outlook by experienced professionals. Intracellular's historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

JavaScript chart by amCharts 3.21.155.05.01.01.09.09.02.03.02.01.010.09.00.00.00.00.00.00.00.00.0Three Month AgoTwo Month AgoOne Month AgoCurrent 246810
JavaScript chart by amCharts 3.21.15Strong Buy Buy Hold Sell Strong Sell

Average Consensus Estimates

JavaScript chart by amCharts 3.21.15BuyBuyThree Month AgoTwo Months AgoOne Month AgoCurrentStrong SellSellHoldBuyStrong Buy
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Intracellular price targets

Intracellular's stock target price is an estimate of its future price, usually made by analysts. Using Intracellular's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Intracellular's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Intracellular's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Intracellular Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Intracellular is a key component of Intracellular valuation and have some predictive power on the future returns of a Intracellular.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Intracellular's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
123.38128.25133.12
Details
Intrinsic
Valuation
LowRealHigh
102.51107.38141.08
Details
Naive
Forecast
LowNextHigh
134.90139.77144.64
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.2-0.32-0.03
Details

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
ESG Investing Idea
ESG Investing
Invested few shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 30 shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 60 shares
Banking Idea
Banking
Invested over 30 shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
FinTech Idea
FinTech
Invested over 60 shares
Dividend Beast Idea
Dividend Beast
Invested over 60 shares
Momentum Idea
Momentum
Invested over 300 shares
Hedge Favorites Idea
Hedge Favorites
Invested over 60 shares
Manufacturing Idea
Manufacturing
Invested over 30 shares
Blockchain Idea
Blockchain
Invested over 20 shares
When determining whether Intracellular Th offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Intracellular's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Intracellular Th Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Intracellular Th Stock:
Check out Macroaxis Advice on Intracellular to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.